One of the most common early signs of prostate cancer is trouble with urination. Urination is affected because the prostate ...

A potential new urine biomarker for prostate cancer not only spots the presence of aggressive tumors, it also indicates the amount of these tumors, according to a recent report.. In a study of ...

Metastatic prostate cancer is a type of cancer that began in the prostate gland and has spread to other areas of the body, ...

PanGIA’s prospective study involved 197 biopsy-confirmed prostate cancer patients and 84 healthy controls, with the test demonstrating strong performance in detecting intermediate- and low-grade ...

PanGIA Biotech Unveils AI-Driven Urine Test Data for Early Prostate Cancer Detection at ASCO 2025. PanGIA Biotech, a leader in non-invasive cancer diagnostics, presented findings at the 2025 ...

A novel AI test created by UCL and the Institute of Cancer Research helps determine which men with high-risk, localized prostate cancer will respond positively to the hormone therapy drug abiraterone.

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists ...